Does RABEPRAZOLE Cause Interstitial lung disease? 82 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 82 reports of Interstitial lung disease have been filed in association with RABEPRAZOLE (Rabeprazole Sodium). This represents 0.7% of all adverse event reports for RABEPRAZOLE.
82
Reports of Interstitial lung disease with RABEPRAZOLE
0.7%
of all RABEPRAZOLE reports
9
Deaths
33
Hospitalizations
How Dangerous Is Interstitial lung disease From RABEPRAZOLE?
Of the 82 reports, 9 (11.0%) resulted in death, 33 (40.2%) required hospitalization, and 15 (18.3%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RABEPRAZOLE. However, 82 reports have been filed with the FAERS database.
What Other Side Effects Does RABEPRAZOLE Cause?
Chronic kidney disease (4,773)
Renal failure (3,135)
Acute kidney injury (2,545)
End stage renal disease (1,295)
Tubulointerstitial nephritis (1,125)
Death (857)
Drug ineffective (732)
Dyspnoea (423)
Gastrooesophageal reflux disease (416)
Headache (387)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which RABEPRAZOLE Alternatives Have Lower Interstitial lung disease Risk?
RABEPRAZOLE vs RACECADOTRIL
RABEPRAZOLE vs RADIATION THERAPY
RABEPRAZOLE vs RADIUM RA-223 DICHLORIDE
RABEPRAZOLE vs RALOXIFENE
RABEPRAZOLE vs RALTEGRAVIR